ES2019721A6 - Metodo de formacion de una molecula de un anticuerpo monoclonal que inmunorreacciona con un sitio de union inducido por receptor. - Google Patents

Metodo de formacion de una molecula de un anticuerpo monoclonal que inmunorreacciona con un sitio de union inducido por receptor.

Info

Publication number
ES2019721A6
ES2019721A6 ES8903328A ES8903328A ES2019721A6 ES 2019721 A6 ES2019721 A6 ES 2019721A6 ES 8903328 A ES8903328 A ES 8903328A ES 8903328 A ES8903328 A ES 8903328A ES 2019721 A6 ES2019721 A6 ES 2019721A6
Authority
ES
Spain
Prior art keywords
receiver
ligand
unión
translation
induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8903328A
Other languages
English (en)
Spanish (es)
Inventor
Edward F Plow
Mark H Ginsberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES2019721A6 publication Critical patent/ES2019721A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES8903328A 1988-10-03 1989-10-03 Metodo de formacion de una molecula de un anticuerpo monoclonal que inmunorreacciona con un sitio de union inducido por receptor. Expired - Fee Related ES2019721A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25275388A 1988-10-03 1988-10-03
US41502989A 1989-09-29 1989-09-29

Publications (1)

Publication Number Publication Date
ES2019721A6 true ES2019721A6 (es) 1991-07-01

Family

ID=26942630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8903328A Expired - Fee Related ES2019721A6 (es) 1988-10-03 1989-10-03 Metodo de formacion de una molecula de un anticuerpo monoclonal que inmunorreacciona con un sitio de union inducido por receptor.

Country Status (8)

Country Link
JP (1) JP2937474B2 (ja)
AU (1) AU639671B2 (ja)
CA (1) CA2000044A1 (ja)
DK (1) DK173362B1 (ja)
ES (1) ES2019721A6 (ja)
FI (1) FI101808B (ja)
NO (1) NO301237B1 (ja)
PT (1) PT91889B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014715D0 (en) * 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS

Also Published As

Publication number Publication date
DK57891A (da) 1991-05-31
PT91889A (pt) 1990-04-30
DK173362B1 (da) 2000-08-14
JPH04501665A (ja) 1992-03-26
PT91889B (pt) 1995-07-03
JP2937474B2 (ja) 1999-08-23
FI101808B1 (fi) 1998-08-31
NO911300L (no) 1991-04-19
NO911300D0 (no) 1991-04-03
NO301237B1 (no) 1997-09-29
AU4652489A (en) 1990-05-14
AU639671B2 (en) 1993-08-05
CA2000044A1 (en) 1990-04-03
FI911586A0 (fi) 1991-04-02
DK57891D0 (da) 1991-04-02
FI101808B (fi) 1998-08-31

Similar Documents

Publication Publication Date Title
CA2047717A1 (en) Monoclonal antibodies for small moieties, methods therefor
DE69434286D1 (de) Immunologische bestimmungen von prostata-spezifischem antigen
ATE402267T1 (de) Verfahren zur herstellung von monoklonalen antikörpern
DE3587360T2 (de) Verfahren zur Herstellung von chimärischen monoklonalen Antikörpern.
ATE81867T1 (de) Monoklonaler antikoerper mit hoher affinitaet zum digoxin.
NO2009012I1 (no) Humanisert anti-humant IL-6 reseptor monoklonalt antistoff
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
NO172596C (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
ATE162311T1 (de) Immunoassay zum nachweis von kollagen oder kollagenfragmenten
EP0102601A3 (en) Monoclonal antibody, a process for its production and the use of this monoclonal antibody
ATE62273T1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
DE3580513D1 (de) Verfahren zur isolierung von monoklonalen antikoerpern aus hybridomas-kulturen.
DE69615843T2 (de) Il-8 antagonisten zur behandlung von asthma
ES2019721A6 (es) Metodo de formacion de una molecula de un anticuerpo monoclonal que inmunorreacciona con un sitio de union inducido por receptor.
ATE217888T1 (de) Monoklonale antikörper gegen leukozyten- spezifische g-protein-gekoppelte rezeptoren
DE3576359D1 (de) Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.
EP0479834A4 (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
KR890008313A (ko) 안티 pci모노클론 항체
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
KR910018041A (ko) Pp4에 대한 모노클로날 항체, 이의 제조방법 및 용도
ATE148163T1 (de) Monoklonale antikörper gegen leptosphaeria
DE3686277T2 (de) Verfahren zur auslese von hybridomen, die spezifische antikoerper gegen unzugaengliche zelloberflaecheantigene erzeugen.
Albert Monoclonal antibodies: advantages and disadvantages in production of test systems
SU967838A1 (ru) Лини дл производства строительных блоков из природного камн
EP0287012A3 (en) Anti-r-binder monoclonal antibody, process for preparing the same and application of the same

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2009-10-03

FD1A Patent lapsed

Effective date: 20061004